Climberhealth

ClimberhealthClimberhealth
Climberhealth

Climberhealth

Stealth modeStealth Mode

AI-powered clinical copilot and medical scribe designed specifically for physical therapists.

2026Active

About

Climber develops an AI-powered clinical copilot and medical scribe tailored for physical therapy and rehabilitation clinics. The platform automates clinical documentation, generates compliant SOAP notes from session audio, and integrates directly with existing Electronic Medical Record (EMR) systems to reduce administrative burden.
Frequently asked

What does Climberhealth do?

Climber develops an AI-powered clinical copilot and medical scribe tailored for physical therapy and rehabilitation clinics. The platform automates clinical documentation, generates compliant SOAP notes from session audio, and integrates directly with existing Electronic Medical Record (EMR) systems to reduce administrative burden.

Is Climberhealth trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Climberhealth is 26 out of 100, based on site security posture and privacy practices.

When was Climberhealth founded?

Climberhealth was founded in 2026.

What industry does Climberhealth operate in?

Climberhealth operates in HealthTech, AI Copilot, AI Chatbot, MedTech, Conversational AI, Speech Recognition.

Scores
Measured, not editorial
Agent Readiness
49/100

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Site Speed
65/100

Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.

Data Trust
26/100

Whether this company is a safe place to put your data: security posture, privacy signals, and reputation evidence we could verify.

Star ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.

Comments

No comments yet. Be the first to share your take.